Newer Direct-Acting Anti-Viral Agents as Sole Therapy of Porphyria Cutanea Tarda in Subjects with Chronic Hepatitis C

Project: Other project

StatusActive
Effective start/end date6/22/174/30/22

Funding

  • Wake Forest University: $39,350.34